Loading...
Guest User
Welcome! Please login.
| IPO Listing At | NSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹33.30 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹33.30 Cr |
| Fresh Issue | ₹31.64 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹105.00-111.00 per share |
| Discount | Retail: 0.00 |
| NSE Code | SOTAC |
| Registrar | Kfin Technologies Ltd. |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 1,200 shares and in multiples thereof
Incorporated in 2015, Sotac Pharmaceuticals Limited is a part of the SOTAC group, based in Gujarat. The company is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis. The company's business is majorly on principle to principle basis with different marketers.
SOTAC is serving over 162 corporate clients on a loan license and/or contract manufacturing basis. With their vast experience in the pharmaceutical segment, the company is growing and enlarging its scale of operations every year.
Sotac Pharmaceuticals established its manufacturing facility in the year 2017. In the year, the company's manufacturing facility was installed with the capacity to manufacture 90 Crore tables/year, and 14 Crore Capsules/year.
With a combined experience of over 59 years in the pharmaceutical manufacturing Industry of the Promoters, the company is blooming and expanding in various horizons.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To Meet Working Capital Requirements | 10.80 |
| 2 | Investment in Subsidiary | 7.00 |
| 3 | Upgradation / Construction of Existing /New Building in the Existing Premises | 5.90 |
| 4 | General Corporate Purpose | 7.40 |
| Period Ended | 30 Sep 2022 | 31 Mar 2022 | 31 Mar 2021 | 31 Mar 2020 |
|---|---|---|---|---|
| Assets | 64.62 | 35.25 | 34.70 | 30.38 |
| Total Income | 39.95 | 73.37 | 48.95 | 28.83 |
| Profit After Tax | 0.47 | 2.88 | -2.37 | 0.09 |
| NET Worth | 7.97 | 6.62 | 2.49 | 3.06 |
| Reserves and Surplus | 5.67 | 4.32 | 0.19 | 0.76 |
| Total Borrowing | 21.86 | 11.35 | 10.36 | 0.15 |
| Amount in ₹ Crore | ||||
| KPI | |
|---|---|
| ROE | 53.1% |
| ROCE | 68.34% |
| Debt / Equity | 1.12% |
| RoNW | 43.47% |
| PAT Margin | 3.94% |
| EBITDA Margin | 8.39% |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 3.58 | |
| P/E (x) | 132.14 | |
| Promoter Holding | 84.63% | |
| Market Cap | ₹122.66 Cr. | |
